FDA/USDA Regulations - Biotech/Drug Laws

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers. The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant.

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis. Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries. Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date	Title	Organization
27 May	FDA Issues Warning Letters to Four Companies Selling Unapproved CBD Products for Food-Producing Animals	Keller and Heckman LLP
26 May	Rhode Island Legalizes Recreational Marijuana and Protects Off-Duty Use	Jackson Lewis P.C.
26 May	FDA Webinar on Action Levels for Lead in Juice	Keller and Heckman LLP
26 May	ISO Publishes Standard on Characterization of CNT and CNF Aerosols for Inhalation Toxicity Tests	Bergeson & Campbell, P.C.
26 May	It's About Time: Federal Court Addresses Delta-8	Ward and Smith, P.A.
26 May	Will FDA’s Proposed Ban on Flavored Tobacco Products Ever be Implemented?	Foley & Lardner LLP
25 May	Connecticut Makes Significant Changes to its Collaborative Drug Therapy Laws	Robinson & Cole LLP
25 May	We Shouldn't Be Surprised the Massachusetts AG Is Doing to PFAS Manufacturers What a Prior AG Did to Tobacco Manufacturers but It's Still Notable!	Mintz
25 May	Medicare Advantage: OIG Report Finds Improper Denials	Foley & Lardner LLP
25 May	Modifications to Proposition 65 Short-Form Warnings on Pause – New Regulatory Proposal to Come	ArentFox Schiff LLP
25 May	Pop-Tarts False Ad Lawsuit Permanently Dismissed	Keller and Heckman LLP
24 May	FDA Denies Request to Exempt D-Tagatose from Added Sugar Labeling	Keller and Heckman LLP
24 May	66,000 Prescriptions in 3 Years: Pharmacy Owners Convicted for Multimillion-Dollar Telemedicine Fraud Scheme	Tycko & Zavareei LLP
23 May	New York Enacts Legislation Regulating Pharmacy Benefit Managers	Polsinelli PC
23 May	University Of Groningen And University Of Graz Scientists Create A Molecular Motor From Lignocellulose	Bergeson & Campbell, P.C.
23 May	New Draft Guidance on FDA Enforcement Discretion for Past-Due NDI Notifications	Keller and Heckman LLP
20 May	EU Seeks Input on Policy for Plants Developed Using New Genomic Techniques	ArentFox Schiff LLP
20 May	The VALID Act: Senate Action Brings FDA Regulation of LDTs Closer to Fruition	Epstein Becker & Green, P.C.
20 May	Recent FDA Enforcement Action Colors Regulatory Landscape for Delta-8 THC Products	Epstein Becker & Green, P.C.
20 May	Implications of the Use of the Defense Production Act in the U.S. Supply Chain	Bradley Arant Boult Cummings LLP